Hypoxia‐inducible factor‐1 α deletion in myeloid lineage attenuates hypoxia‐induced pulmonary hypertension

Physiological Reports

  ^{1    2    2    2    3    4    5} 

[1] Center for Disruptive Cardiovascular Medicine, Department of Advanced Cardiovascular Regulation and Therapeutics, Kyushu University, Fukuoka, Japan;Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan;Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan;Center for Disruptive Cardiovascular Medicine, Department of Advanced Cardiovascular Regulation and Therapeutics, Kyushu University, Fukuoka, Japan;Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan;Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan;Center for Disruptive Cardiovascular Medicine, Department of Advanced Cardiovascular Regulation and Therapeutics, Kyushu University, Fukuoka, Japan;International University of Health and Welfare, Fukuoka, Japan;Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan;Department of Cardiology, Harasanshin Hospital, Fukuoka, Japan;

关键词: Hypoxia;    hypoxia‐inducible factor;    macrophages;    pulmonary hypertension;   

DOI  :  10.14814/phy2.14025

来源: publisher

【 授权许可】

Unknown